Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -11.27
- Piotroski Score 4.00
- Grade Buy
- Symbol (EKSO)
- Company Ekso Bionics Holdings, Inc.
- Price $0.68
- Changes Percentage (-0.78%)
- Change -$0.01
- Day Low $0.67
- Day High $0.72
- Year High $3.13
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/27/2025
- Fiscal Year End N/A
- Average Stock Price Target $2.00
- High Stock Price Target $2.00
- Low Stock Price Target $2.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.97
- Trailing P/E Ratio -1.13
- Forward P/E Ratio -1.13
- P/E Growth -1.13
- Net Income $-15,198,000
Income Statement
Quarterly
Annual
Latest News of EKSO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Q3 2024 Ekso Bionics Holdings Inc Earnings Call
Matt Steinberg from Finn Partners introduces Scott Davis, CEO, and Jerome Wong, CFO, of Ekso Bionics in a financial results call for Q3 2024....
By Yahoo! Finance | 1 month ago -
Ekso Bionics Holdings Inc (EKSO) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...
CEO Scott Davis stated that about half of the 33 placements during the quarter were in Europe and APAC regions, with most outside the US. CMS claims were filed in Q3, with one reimbursed and two pendi...
By Yahoo! Finance | 1 month ago -
Eksons Corporation Berhad's (KLSE:EKSONS) Earnings Offer More Than Meets The Eye
Despite a positive earnings report from Eksons Corporation Berhad, the market showed a lackluster response. Unusual expenses impacted profits but may not be repeated, suggesting potential for improved...
By Yahoo! Finance | 3 months ago
